Mark R. Hake

Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Rite Aid’s Firm Fundamentals Will Lead To A Higher Stock Price

By Mark R. Hake, CFA

CEO-led turnaround has made RAD stock very valuable, and cheap based on 2020 outlook, as firm fundamentals lead to a higher stock price.

Micron Stock Is Finally Climbing Out of a Cyclical Bottom

By Mark R. Hake, CFA

If Micron's free cash flow stays headed higher, MU stock will see a boost. My estimates put it at a value of $85 today.

Gilead’s Coronavirus Drug Could Propel GILD Stock Much Higher

By Mark R. Hake, CFA

Gilead's coronavirus drug could propel GILD stock much higher. If Gilead's coronavirus drug remdesivir has successful trials, GILD stock could skyrocket.

Qualcomm Stock Looks Cheap as Global 5G Rollout Kicks In

By Mark R. Hake, CFA

Qualcomm stock looks cheap as 5G rollout kicks in. At 16x its expected Q4 run-rate earnings, it's too cheap given its earnings growth.

Freeport-McMoRan Stock Is Focused on 2021

By Mark R. Hake, CFA

Freeport-McMoRan stock is all set up for a big 2021. Investors should expect a huge dividend hike in 2021 that will send it surging.

Load More